Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic-Reference-Cited by-同舟云学术

Safety and immunogenicity of shorter interval schedules of the novel oral poliovirus vaccine type 2 in infants: a phase 3, randomised, controlled, non-inferiority study in the Dominican Republic

Published:2023-12 Issue: Volume: Page:
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Rivera Mejía Luis,Peña Méndez Lourdes,Bandyopadhyay Ananda Sankar,Gast Chris,Mazara Sonia,Rodriguez Katy,Rosario Nadia,Zhang Yiting,Mainou Bernardo A,Jimeno Jose,Aguirre Gabriela,Rüttimann Ricardo

Funder

Bill & Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference17 articles.

1. Vaccine-derived polioviruses;Burns;J Infect Dis,2014

2. Polio endgame: the global introduction of inactivated polio vaccine;Patel;Expert Rev Vaccines,2015

3. Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine—worldwide, 2016;Hampton;MMWR Morb Mortal Wkly Rep,2016

4. Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules;Bandyopadhyay;Vaccine,2017

5. Engineering the live-attenuated polio vaccine to prevent reversion to virulence;Yeh;Cell Host Microbe,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022;Emerging Infectious Diseases;2024-04

2. First Africa-based clinical trial for novel type 2 oral poliovirus vaccine;The Lancet;2024-03

3. Novel oral polio vaccine for serotype 2: new hope;The Lancet Infectious Diseases;2023-12